327 related articles for article (PubMed ID: 27562745)
1. Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study.
McGillen JB; Anderson SJ; Dybul MR; Hallett TB
Lancet HIV; 2016 Sep; 3(9):e441-e448. PubMed ID: 27562745
[TBL] [Abstract][Full Text] [Related]
2. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
McGillen JB; Anderson SJ; Hallett TB
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
[TBL] [Abstract][Full Text] [Related]
3. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.
Jewell BL; Mudimu E; Stover J; Ten Brink D; Phillips AN; Smith JA; Martin-Hughes R; Teng Y; Glaubius R; Mahiane SG; Bansi-Matharu L; Taramusi I; Chagoma N; Morrison M; Doherty M; Marsh K; Bershteyn A; Hallett TB; Kelly SL;
Lancet HIV; 2020 Sep; 7(9):e629-e640. PubMed ID: 32771089
[TBL] [Abstract][Full Text] [Related]
4. Subnational mapping of HIV incidence and mortality among individuals aged 15-49 years in sub-Saharan Africa, 2000-18: a modelling study.
Local Burden of Disease HIV Collaborators
Lancet HIV; 2021 Jun; 8(6):e363-e375. PubMed ID: 34087097
[TBL] [Abstract][Full Text] [Related]
5. Mapping and characterising areas with high levels of HIV transmission in sub-Saharan Africa: A geospatial analysis of national survey data.
Bulstra CA; Hontelez JAC; Giardina F; Steen R; Nagelkerke NJD; Bärnighausen T; de Vlas SJ
PLoS Med; 2020 Mar; 17(3):e1003042. PubMed ID: 32142509
[TBL] [Abstract][Full Text] [Related]
6. Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000-20: a modelling study using survey and HIV testing programme data.
Giguère K; Eaton JW; Marsh K; Johnson LF; Johnson CC; Ehui E; Jahn A; Wanyeki I; Mbofana F; Bakiono F; Mahy M; Maheu-Giroux M
Lancet HIV; 2021 May; 8(5):e284-e293. PubMed ID: 33667411
[TBL] [Abstract][Full Text] [Related]
7. Reducing the spread of HIV infection in sub-Saharan Africa: some demographic and economic implications.
Rowley JT; Anderson RM; Ng TW
AIDS; 1990 Jan; 4(1):47-56. PubMed ID: 2317308
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of combination packages for HIV-1 prevention in sub-Saharan Africa depends on partnership network structure: a mathematical modelling study.
Jenness SM; Goodreau SM; Morris M; Cassels S
Sex Transm Infect; 2016 Dec; 92(8):619-624. PubMed ID: 27288415
[TBL] [Abstract][Full Text] [Related]
9. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study.
Anderson SJ; Cherutich P; Kilonzo N; Cremin I; Fecht D; Kimanga D; Harper M; Masha RL; Ngongo PB; Maina W; Dybul M; Hallett TB
Lancet; 2014 Jul; 384(9939):249-56. PubMed ID: 25042235
[TBL] [Abstract][Full Text] [Related]
10. The potential impact of male circumcision on HIV in Sub-Saharan Africa.
Williams BG; Lloyd-Smith JO; Gouws E; Hankins C; Getz WM; Hargrove J; de Zoysa I; Dye C; Auvert B
PLoS Med; 2006 Jul; 3(7):e262. PubMed ID: 16822094
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa: results from five independent models.
Bansi-Matharu L; Mudimu E; Martin-Hughes R; Hamilton M; Johnson L; Ten Brink D; Stover J; Meyer-Rath G; Kelly SL; Jamieson L; Cambiano V; Jahn A; Cowan FM; Mangenah C; Mavhu W; Chidarikire T; Toledo C; Revill P; Sundaram M; Hatzold K; Yansaneh A; Apollo T; Kalua T; Mugurungi O; Kiggundu V; Zhang S; Nyirenda R; Phillips A; Kripke K; Bershteyn A
Lancet Glob Health; 2023 Feb; 11(2):e244-e255. PubMed ID: 36563699
[TBL] [Abstract][Full Text] [Related]
12. The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling study.
Akullian A; Morrison M; Garnett GP; Mnisi Z; Lukhele N; Bridenbecker D; Bershteyn A
Lancet HIV; 2020 May; 7(5):e348-e358. PubMed ID: 32061317
[TBL] [Abstract][Full Text] [Related]
13. The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS.
Kelly SL; Martin-Hughes R; Stuart RM; Yap XF; Kedziora DJ; Grantham KL; Hussain SA; Reporter I; Shattock AJ; Grobicki L; Haghparast-Bidgoli H; Skordis-Worrall J; Baranczuk Z; Keiser O; Estill J; Petravic J; Gray RT; Benedikt CJ; Fraser N; Gorgens M; Wilson D; Kerr CC; Wilson DP
Lancet HIV; 2018 Apr; 5(4):e190-e198. PubMed ID: 29540265
[TBL] [Abstract][Full Text] [Related]
14. Reductions in HIV incidence are likely to increase the importance of key population programmes for HIV control in sub-Saharan Africa.
Garnett GP
J Int AIDS Soc; 2021 Jul; 24 Suppl 3(Suppl 3):e25727. PubMed ID: 34189844
[TBL] [Abstract][Full Text] [Related]
15. Future HIV epidemic trajectories in South Africa and projected long-term consequences of reductions in general population HIV testing: a mathematical modelling study.
Rautenbach SP; Whittles LK; Meyer-Rath G; Jamieson L; Chidarikire T; Johnson LF; Imai-Eaton JW
Lancet Public Health; 2024 Apr; 9(4):e218-e230. PubMed ID: 38553141
[TBL] [Abstract][Full Text] [Related]
16. The Incidence Patterns Model to Estimate the Distribution of New HIV Infections in Sub-Saharan Africa: Development and Validation of a Mathematical Model.
Bórquez A; Cori A; Pufall EL; Kasule J; Slaymaker E; Price A; Elmes J; Zaba B; Crampin AC; Kagaayi J; Lutalo T; Urassa M; Gregson S; Hallett TB
PLoS Med; 2016 Sep; 13(9):e1002121. PubMed ID: 27622516
[TBL] [Abstract][Full Text] [Related]
17. AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention.
Hunter DJ
Epidemiology; 1993 Jan; 4(1):63-72. PubMed ID: 8420583
[TBL] [Abstract][Full Text] [Related]
18. Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era.
Eaton JW; Bacaër N; Bershteyn A; Cambiano V; Cori A; Dorrington RE; Fraser C; Gopalappa C; Hontelez JA; Johnson LF; Klein DJ; Phillips AN; Pretorius C; Stover J; Rehle TM; Hallett TB
Lancet Glob Health; 2015 Oct; 3(10):e598-608. PubMed ID: 26385301
[TBL] [Abstract][Full Text] [Related]
19. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
[TBL] [Abstract][Full Text] [Related]
20. Consequences of a changing US strategy in the global HIV investment landscape.
McGillen JB; Sharp A; Honermann B; Millett G; Collins C; Hallett TB
AIDS; 2017 Nov; 31(18):F19-F23. PubMed ID: 29112075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
